Senior Director, Medicinal Chemistry
Arvinas, Inc.
Keith Hornberger, PhD is Senior Director of Medicinal Chemistry at Arvinas, Inc., where he leads the medicinal chemistry team supporting the discovery of PROTAC™ targeted protein degraders for oncology. Over the last 20 years, he has held multiple positions of increasing responsibility in preclinical drug discovery at GlaxoSmithKline, OSI Pharmaceuticals (a subsidiary of Astellas), Boehringer Ingelheim, and most recently Arvinas, Inc., where he has been since 2016. He completed his PhD in organic chemistry at Columbia University in 2002.
Disclosure information not submitted.
Monday, October 17, 2022
10:30 AM – 11:00 AM ET